Allogene Therapeutics, Inc. (ALLO)
2.035
-0.06
(-2.63%)
USD |
NASDAQ |
Aug 24, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Debt to Equity Ratio : 0.1811 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1811 |
| March 31, 2026 | 0.2906 |
| December 31, 2025 | 0.2846 |
| September 30, 2025 | 0.27 |
| June 30, 2025 | 0.2525 |
| March 31, 2025 | 0.2307 |
| December 31, 2024 | 0.215 |
| September 30, 2024 | 0.1995 |
| June 30, 2024 | 0.1829 |
| March 31, 2024 | 0.2077 |
| December 31, 2023 | 0.1857 |
| September 30, 2023 | 0.1658 |
| June 30, 2023 | 0.1577 |
| March 31, 2023 | 0.1683 |
| December 31, 2022 | 0.1519 |
| September 30, 2022 | 0.1386 |
| June 30, 2022 | 0.1292 |
| March 31, 2022 | 0.0849 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.079 |
| September 30, 2021 | 0.0555 |
| June 30, 2021 | 0.0531 |
| March 31, 2021 | 0.0511 |
| December 31, 2020 | 0.0498 |
| September 30, 2020 | 0.048 |
| June 30, 2020 | 0.046 |
| March 31, 2020 | 0.0879 |
| December 31, 2019 | 0.0816 |
| September 30, 2019 | 0.0613 |
| June 30, 2019 | 0.0537 |
| March 31, 2019 | 0.0515 |
| December 31, 2018 | 0.049 |
| September 30, 2018 | 0.5755 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cartesian Therapeutics, Inc. | -0.5099 |
| Beam Therapeutics, Inc. | 0.2317 |
| Kyverna Therapeutics, Inc. | 0.1993 |
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 550.09M |
| Total Liabilities (Quarterly) | 113.92M |
| Shareholders Equity (Quarterly) | 436.18M |
| Current Ratio | 10.72 |
| Net Debt Paydown Yield | 0.28% |